Form 4 holding
Director
Sage Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 128,046
- Estimated value
- $2,467,446
- Report date
- 28 Nov 2023
- Price
- $19.27
- Ownership
- Direct
Jeffrey M. Jonas - Director at Sage Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- SAGE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jeffrey M. Jonas since 16 Jun 2025
Reported holdings for Jeffrey M. Jonas in Sage Therapeutics, Inc.
Form 4 holding
Director
Sage Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 12,500
- Estimated value
- Report date
- 10 Jun 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jeffrey M. Jonas in Sage Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.